Patients with congenital myasthenia associated with end-plate acetylcholinesterase deficiency show normal sequence, mRNA splicing, and assembly of catalytic subunits.

Registos relacionados

• Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).
  Por: Donger, C, et al.
  Publicado em: (1998)
• Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A-->G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): how does G at position +3 result in aberrant splicing?
  Por: Ohno, K, et al.
  Publicado em: (1999)
• Antigenic and structural differences in the catalytic subunits of the molecular forms of acetylcholinesterase.
  Por: Doctor, B P, et al.
  Publicado em: (1983)
• BENEFICIAL EFFECTS OF ALBUTEROL IN CONGENITAL ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY AND DOK-7 MYASTHENIA
  Por: Liewluck, Teerin, et al.
  Publicado em: (2011)
• The C-terminal T peptide of acetylcholinesterase enhances degradation of unassembled active subunits through the ERAD pathway
  Por: Belbeoc’h, Stéphanie, et al.
  Publicado em: (2003)